PreViser Announces Evidence-Based Dentistry as an Interceptor to Protect Health

MT. VERNON, Wash., March 24 /PRNewswire/ -- In response to growing interest in its evidence-based dentistry, PreViser Corporation has launched new international health technology.

PreViser's patented and clinically validated periodontal risk/disease calculator - the only one in the industry - and its risk calculator for tooth decay are main features of the technology. Known as the Oral Health Information Suite(TM), this software allows practitioners to determine their patients' susceptibility to gum disease and tooth loss before they occur.

The enhanced software is compatible with international computer operating systems and is more user-friendly, with improved transmission speed, increased reliability and quicker downloading. Besides the U.S. and Canada, 20 countries are already benefiting from PreViser's assessment tools.

"New treatment approaches become clear as one understands disease risk, which is the third dimension of care," said PreViser's CEO Carl Loeb.

Part of the demand for PreViser's software stems from its impact in helping to contain public dental/medical costs, especially in countries where the government subsidizes or pays for all those costs, Loeb explained. In the U.S., PreViser's tools offer an attractive method for helping to limit rising dental/medical insurance costs, while improving oral health.

Practitioners who utilize the technology can order brochures and access online tutorials to help educate their patients about preventive care.

"PreViser is on the cutting-edge, just like its CEO Carl Loeb and its clinical founders, including Dr. Randy Nolf, Dr. John Martin and Dr. Roy Page. They do an outstanding job in advancing this technology that indicates future ailments," said public affairs spokesperson Daisy Gallagher, CEO of Gallagher & Gallagher, Inc.

Low birth weight babies have been linked to mothers with periodontal disease, according to research conducted by Margery Jeffcoat of the University of Pennsylvania. The National Institutes of Health has established a direct linkage between the bacteria causing oral disease and that presumed responsible for many forms of cardiovascular disease.

New clinical users can take advantage of a 30-day complimentary trial evaluation of PreViser's software. It can be downloaded free from http://www.previser.com/.

PreViser's technology was conceived by Dr. Randy Nolf, Dr. John Martin, Dr. Roy Page and colleagues nationwide, and tested through research at the University of Washington and in Boston. Based in Mount Vernon, Washington, the company specializes in patented Web-enabled support tools and treatment planning for dentists, hygienists and their patients.